Success Metrics

Clinical Success Rate
84.1%

Based on 195 completed trials

Completion Rate
84%(195/232)
Active Trials
186(30%)
Results Posted
38%(74 trials)
Terminated
37(6%)

Phase Distribution

Ph early_phase_1
6
1%
Ph phase_2
259
42%
Ph not_applicable
56
9%
Ph phase_1
92
15%
Ph phase_3
115
18%
Ph phase_4
16
3%

Phase Distribution

98

Early Stage

259

Mid Stage

131

Late Stage

Phase Distribution544 total trials
Early Phase 1First-in-human
6(1.1%)
Phase 1Safety & dosage
92(16.9%)
Phase 2Efficacy & side effects
259(47.6%)
Phase 3Large-scale testing
115(21.1%)
Phase 4Post-market surveillance
16(2.9%)
N/ANon-phased studies
56(10.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.0%

195 of 267 finished

Non-Completion Rate

27.0%

72 ended early

Currently Active

186

trials recruiting

Total Trials

623

all time

Status Distribution
Active(236)
Completed(195)
Terminated(72)
Other(120)

Detailed Status

Completed195
Recruiting150
unknown115
Not yet recruiting47
Terminated37
Active, not recruiting36

Development Timeline

Analytics

Development Status

Total Trials
623
Active
186
Success Rate
84.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (1.1%)
Phase 192 (16.9%)
Phase 2259 (47.6%)
Phase 3115 (21.1%)
Phase 416 (2.9%)
N/A56 (10.3%)

Trials by Status

withdrawn356%
active_not_recruiting366%
suspended51%
unknown11518%
recruiting15024%
completed19531%
not_yet_recruiting478%
enrolling_by_invitation30%
terminated376%

Recent Activity

Clinical Trials (623)

Showing 20 of 623 trialsScroll for more
NCT07391774Phase 3

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Recruiting
NCT07425054Phase 2

ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer

Not Yet Recruiting
NCT01154920Phase 2

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Active Not Recruiting
NCT07392892Phase 2

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Recruiting
NCT07637851Phase 1

Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer

Not Yet Recruiting
NCT04302025Phase 2

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Recruiting
NCT03939481

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

Active Not Recruiting
NCT07476287Phase 2

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Recruiting
NCT07188532Not Applicable

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

Recruiting
NCT07222800Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Recruiting
NCT07627620Phase 2

Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer

Not Yet Recruiting
NCT06596473Phase 1

A Study of BG-C477 in Participants With Advanced Solid Tumors

Recruiting
NCT07226999Phase 2

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Recruiting
NCT05981703Phase 1

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Recruiting
NCT05673148Phase 3

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Recruiting
NCT04643366Phase 2

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Recruiting
NCT07620548Phase 2

Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas

Not Yet Recruiting
NCT07162506Phase 2

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Recruiting
NCT07613151

Negative Hormone Receptor and APOcrine Lobular Invasive Breast Cancer

Recruiting
NCT02392429Phase 2

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
623